A cheap drug that has been around for 30 years, known as naltrexone, may be the latest answer to Fibromyalgia pain sufferers. Researchers at Stanford University have reported that a small study using naltrexone, typically a prescription used to treat drug addiction, reduced Fibromyalgia pain by as much as 30% more than a placebo.
These results were based on a study that was done on 10 female participants for a total of 14 weeks. All of the participants were given naltrexone part of the time and a placebo part of the time but they didn’t know which they were getting when.
Study author, Dr. Sean Mackey, said of the research:
“Patients’ reactions were really quite profound. Some people decided to come off other medications. Some people went back to work really improving their quality of life.”
If larger studies are done on naltrexone, and it is eventually approved for the treatment of Fibromyalgia, the cost would only run patients around $40 a month – considerably cheaper than the few other FDA approved Fibromyalgia drugs.
Personally, with the study only including 10 female participants, I feel this “news” might be a little premature and a larger study should have been done or the results shouldn’t have been made public until a larger study was done. With only 10 study participants, I think it’s way too early to get excited.